Chiesi Joins:
Companies
Industries
Countries
with the shared goal to use business as a force for good.
Becoming a B Corp requires achieving a minimum score on the B Impact Assessment, a rigorous assessment of the company’s impact done by an external 3rd party B Lab on its governance, workers, customers, community, and environment, and publishing a yearly Impact Report for transparency.
PATIENTS & HCPS
ETHICS & TRANSPARENCY
ENVIRONMENT
WORKERS
COMMUNITIES
It is a commitment that even if we are not perfect, we will continuously and transparently measure, improve and challenge ourselves to minimise our negative impact and maximise our positive impact.
At Chiesi, generations after generations, we follow our true calling: to care for others, to improve the quality of life of all people, especially the most vulnerable ones.
We are a family business, that means we care for generations, for the long term.
So, it felt natural for Chiesi to become a B-Corp. Balancing profit, people and planet.
Since 2019, We are the largest pharmaceutical company to be awarded with B-Corp certification.
It is important for us to be a B Corp as it reinforces our commitment to the Sustainable Development Goals from the Paris agreement, especially SDG 3 Good Health for all at all ages which is very linked to a pharmaceutical company.
We have concrete commitments and actions
For our environment
For our patients
For our society
